Search results
Results from the WOW.Com Content Network
On November 30, 2011, Washington State Governor Christine Gregoire announced the filing of a petition [70] [71] with the U.S. Drug Enforcement Administration asking the agency to reclassify marijuana as a Schedule 2 drug, which will allow its use for treatment – prescribed by doctors and filled by pharmacists. Gov.
The drug or other substance has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use of the drug or other substance under medical supervision. The complete list of Schedule I substances is as follows. [1] The Administrative Controlled Substances Code Number for each substance is included.
The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug or other substances may lead to severe psychological or physical dependence. The complete list of Schedule II substances is as follows.
Marijuana has been considered a Schedule I drug since the Controlled Substances Act was signed in 1970, falling into the same category as substances like heroin, MDMA or Ecstasy.
Marijuana policy could be changing. Find out what the a Schedule 3 drug is, and what it means for marijuana users.
While marijuana has been decriminalized throughout many states in the US, it remains a Schedule I drug as of October 2024. However, on January 12, 2024, the FDA announced its recommendation that marijuana be moved to a Schedule III drug, which is a much less strictly-regulated category and would acknowledge its potential for medical use. [67]
Since 2011, prosecutors can choose not to prosecute possession of small quantities of cannabis for personal use if it is a first offense or if the person is drug dependent. [208] Possession of large quantities of drugs can result in up to 10 years in prison. [209] Portugal: Decriminalized up to 25 g (7 ⁄ 8 oz) of herb or 5 g (3 ⁄ 16 oz) of ...
The bill also fully removed or "descheduled" low-THC cannabis products from the Controlled Substances Act, where they had been listed as Schedule I drugs since the CSA's inception in 1970. [4] [12] 2022: The Medical Marijuana and Cannabidiol Research Expansion Act is signed into law to allow cannabis to be more easily researched for medical ...